Graft-versus-host reactions and bone-marrow transplantation

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

Three areas of bone-marrow transplantation have developed particularly rapidly during the past year. First, increasing numbers of bone-marrow transplants using matched unrelated donors or HLA-mismatched family members have been successfully performed. Second, trials of recombinant hemopoietic growth factors have shown these agents can accelerate hemopoietic recovery after bone-marrow transplant and reduce the incidence of infections and other post-transplant complications. But potentially the most important advances have come in a series of separate observations, which in conjunction suggest mechanisms by which the anti-leukemic activity of an allograft may be separated from its ability to induce graft-versus-host disease.

Original languageEnglish (US)
Pages (from-to)752-757
Number of pages6
JournalCurrent Opinion in Immunology
Volume3
Issue number5
DOIs
StatePublished - Oct 1991

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Graft-versus-host reactions and bone-marrow transplantation'. Together they form a unique fingerprint.

Cite this